| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JC.81.6.2209 |
| P698 | PubMed publication ID | 8964853 |
| P50 | author | Jens Otto Lunde Jørgensen | Q40020467 |
| P2093 | author name string | Jurik AG | |
| Christiansen JS | |||
| Vahl N | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2209-2215 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. | |
| P478 | volume | 81 |
| Q37125980 | Age-related changes in body composition of bovine growth hormone transgenic mice |
| Q36816921 | Aging and the growth hormone/insulin like growth factor-I axis |
| Q60690810 | Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index |
| Q36964832 | Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion |
| Q37101164 | Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis |
| Q24672540 | Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes? |
| Q57420699 | Consequences of stopping growthhormone (GH) therapy in young GH deficient patients with childhood onset disease |
| Q52165318 | Developmental changes in the relationship between IGF-I and body composition during puberty. |
| Q34034938 | Effects of growth hormone treatment on visceral adipose tissue. |
| Q77917193 | Endocrine aspects of ageing in the male |
| Q44660492 | Evaluation of growth hormone stimulation tests in cured acromegalic patients |
| Q35103887 | GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90 |
| Q36494377 | Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men |
| Q51561332 | Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults. |
| Q51553784 | Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial. |
| Q35946598 | Growth hormone and glucose homeostasis |
| Q35814492 | Growth hormone outgrows growth |
| Q46969262 | Growth hormone responses to low-dose physostigmine in elderly vs. young women and men. |
| Q35204593 | Growth hormone responses to sub-maximal and sprint exercise |
| Q37396676 | Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone |
| Q51315747 | Growth hormone-releasing effects of whole body vibration alone or combined with squatting plus external load in severely obese female subjects. |
| Q33569163 | Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? |
| Q33542811 | Interaction between body composition, leptin and growth hormone status |
| Q50901751 | L-arginine and insulin-tolerance tests in the diagnosis of adult growth hormone deficiency: influence of confounding factors. |
| Q55042126 | Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. |
| Q35667568 | Mechanisms underlying the neuroendocrine response to physical exercise |
| Q30306091 | Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender |
| Q34815430 | Pharmacokinetics and acute lipolytic actions of growth hormone. Impact of age, body composition, binding proteins, and other hormones |
| Q38344589 | Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year |
| Q35197911 | Serum levels of insulin-like growth factor I and its binding proteins in health and disease |
| Q38097351 | The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations |
| Q51766789 | The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects. |
| Q42503460 | The in vitro effect of leptin on growth hormone secretion from primary cultured ovine somatotrophs |
| Q34036936 | Variability in growth hormone stimulation tests |
| Q80943604 | Young elite athletes of different sport disciplines present with an increase in pulsatile secretion of growth hormone compared with non-elite athletes and sedentary subjects |
Search more.